Explore 1P-ETH-LAD | TiHKAL · info

Exploring 1P-ETH-LAD. To explore a different substance…

Names

1P-ETH-LAD
1-Propionyl-6-ethyl-6-nor-lysergic acid diethyamide

IUPAC names

N,N,6-Triethyl-1-propanoyl-9,10-didehydroergoline-8β-carboxamide
(6aR,9R)-N,N,7-Triethyl-4-propanoyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
(8β)-N,N,6-Triethyl-1-propanoyl-9,10-didehydroergoline-8-carboxamide

ID 5917 · Formula C₂₄H₃₁N₃O₂ · Molecular weight 393.522

InChI InChI=1S/C24H31N3O2/c1-5-22(28)27-15-16-13-21-19(18-10-9-11-20(27)23(16)18)12-17(14-26(21)8-4)24(29)25(6-2)7-3/h9-12,15,17,21H,5-8,13-14H2,1-4H3/t17-,21-/m1/s1

InChI Key MLOFCBXSOAYCIF-DYESRHJHSA-N This stereoisomer Any stereoisomer

SMILES CCN1C[C@@H](C=C2[C@H]1Cc1cn(c3c1c2ccc3)C(=O)CC)C(=O)N(CC)CC

ChemSpider 52085137
PubChem 119025859
Wikidata Q27279820
Wikipedia 1P-ETH-LAD
PsychonautWiki 1P-ETH-LAD
bluelight.org The Small & Handy 1P-ETH-LAD Thread

Brandt, SD; Kavanagh, PV; Westphal, F; Elliott, SP; Wallach, J; Stratford, A; Nichols, DE; Halberstadt, AL. Return of the lysergamides. Part III: Analytical characterization of N⁶-ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD). Drug Test. Anal., 1 Oct 2017, 9 (10), 1641-1649. 1.2 MB. https://doi.org/10.1002/dta.2196

Brandt, SD; Kavanagh, PV; Twamley, B; Westphal, F; Elliott, SP; Wallach, J; Stratford, A; Klein, LM; McCorvy, JD; Nichols, DE; Halberstadt, AL. Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775). Drug Test. Anal., 1 Feb 2018, 10 (2), 310-322. 1.2 MB. https://doi.org/10.1002/dta.2222

Brandt, SD; Kavanagh, PV; Westphal, F; Stratford, A; Elliott, SP; Dowling, G; Wallach, J; Halberstadt, AL. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1‐butanoyl‐d‐lysergic acid diethylamide (1B‐LSD). Drug Test. Anal., 13 May 2019, 11 (8), 1122-1133. 1.5 MB. https://doi.org/10.1002/dta.2613 #1P-ETH-LAD LC,MS,NMR,IR,UV

EMCDDA. New drugs in Europe, 2017, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Aug 2017. 672 kB. #31

Wagmann, L; Richter, LHJ; Kehl, T; Wack, F; Bergstrand, MP; Brandt, SD; Stratford, A; Maurer, HH; Meyer, MR. In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures. Anal. Bioanal. Chem., 1 Jul 2019, 411 (19), 4751-4763. 3.8 MB. https://doi.org/10.1007/s00216-018-1558-9 #21 MS

Elliott, SP; Holdbrook, T; Brandt, SD. Prodrugs of new psychoactive substances (NPS): A new challenge. J. Forensic Sci., 13 Jan 2020, 65 (3), 913-920. 815 kB. https://doi.org/10.1111/1556-4029.14268 #1P-ETH-LAD MS,UV

Brandt, SD; Kavanagh, PV; Westphal, F; Stratford, A; Odland, AU; Klein, AK; Dowling, G; Dempster, NM; Wallach, J; Passie, T; Halberstadt, AL. Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD). Drug Test. Anal., 16 Mar 2020, 12 (6), 812-826. 16.3 MB. https://doi.org/10.1002/dta.2789 #1P-ETH-LAD GC,LC,MS,NMR,IR

Brandt, SD; Kavanagh, PV; Westphal, F; Pulver, B; Schwelm, HM; Whitelock, K; Stratford, A; Auwärter, V; Halberstadt, AL. Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P‐AL‐LAD. Drug Test. Anal., 29 May 2022, 14 (8), 1503-1518. 1.3 MB. https://doi.org/10.1002/dta.3281 #1P-ETH-LAD GC,LC,MS,NMR

A-THPMINACA · AD-THPINACA · ATHPINACA · Adamantyl-THPINACA · SGT-40

(isomer 2) ATHPINACA · 2AD-ATHPINACA · SGT-194

1B-LSD

(acetyl) Etonitazene · 5-Acetyletodesnitazene · LS-87139

7 Dec 2019 · · Isomer Design